Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon CancerCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Spinocerebellar Degenerations, brain disorder, central nervous system disorder, cerebellar disorder, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, hereditary disease, inherited neurodegenerative disorder, intestinal disorder, malignant colon neoplasm, neoplasm, nervous system disorder, neurodegenerative disease, spinal cord disorder, type 1 diabetes mellitus 12Not yet recruitingPhase 22026-09-08NCT07808151

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Solstice Oncology, Inc.1

30 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Investigator SiteMilanItaly1
Investigator SiteChicagoUnited States1
Investigator SiteGlasgowUnited Kingdom1
Investigator SiteBarcelonaSpain1
Investigator SiteLondonUnited Kingdom1
Investigator SiteTampaUnited States1
Investigator SiteBaltimoreUnited States1
Investigator SiteMadridSpain1
Investigator SiteLos AngelesUnited States1
Investigator SiteNew YorkUnited States1
Investigator SiteNew YorkUnited States1
Investigator SiteLeuvenBelgium1
Investigator SiteAmsterdamNetherlands1
Investigator SiteClevelandUnited States1
Investigator SiteAnderlechtBelgium1
Investigator SiteBostonUnited States1
Investigator SiteLiègeBelgium1
Investigator SiteNaplesItaly1
Investigator SiteGhentBelgium1
Investigator SiteLeedsUnited Kingdom1
Investigator SiteNashvilleUnited States1
Investigator SiteBonheidenBelgium1
Investigator SiteOstendBelgium1
Investigator SiteNew YorkUnited States1
Investigator SiteSeattleUnited States1